Similarities between the epstein-barr virus (EBV) nuclear protein ebna1 and the pioneer transcription factor foxa: Is ebna1 a "bookmarking" oncoprotein that alters the host cell epigenotype?

Pathogens

Volumn 1, Issue 1, 2012, Pages 37-51

  Niller, Hans Helmut ^a   Minarovits, Janos ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

Author keywords

Chromatin; CpG methylation; DNA looping; Histone; Orip

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; FORKHEAD TRANSCRIPTION FACTOR; ONCOPROTEIN; TRANSCRIPTION FACTOR FOX A; UNCLASSIFIED DRUG;

CARCINOGENESIS; CHROMATIN; CHROMOSOME; DEMETHYLATION; DNA REPLICATION; DNA SEQUENCE; EPIGENETICS; EPISOME; EPSTEIN BARR VIRUS; GENE; GENOME; HUMAN; LYMPHOBLASTOID CELL LINE; NEOPLASM; NONHUMAN; NUCLEOSOME; REVIEW;

EID: 84886645148     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens1010037     Document Type: Review

References (96)

1. Niller, H.H.; Wolf, H.; Minarovits, J. Epstein-Barr Virus. In Latency Strategies of Herpesviruses; Minarovits, J., Gonczol, E., Valyi-Nagy, T., Eds.; Springer: New York, NY, USA, 2007; pp. 154-191.
2. Niller, H.H.; Wolf, H.; Minarovits, J. Regulation and dysregulation of Epstein-Barr virus latency: Implications for the development of autoimmune diseases. Autoimmunity 2008, 41, 298-328.
3. Lindner, S.E.; Sugden, B. The plasmid replicon of Epstein-Barr virus: Mechanistic insights into efficient, licensed, extrachromosomal replication in human cells. Plasmid 2007, 58, 1-12.
4. Srinivas, S.K.; Sixbey, J.W. Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2. J. Virol. 1995, 69, 8155-8158.
5. Gruhne, B.; Sompallae, R.; Marescotti, D.; Kamranvar, S.A.; Gastaldello, S.; Masucci, M.G. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc. Natl. Acad. Sci. USA 2009, 106, 2313-2318.
6. Cao, J.Y.; Mansouri, S.; Frappier, L. Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses. J. Virol. 2012, 86, 382-394.
7. Saridakis, V.; Sheng, Y.; Sarkari, F.; Holowaty, M.N.; Shire, K.; Nguyen, T.; Zhang, R.G.; Liao, J.; Lee, W.; Edwards, A.M. et al. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol. Cell. 2005, 18, 25-36.
8. Sivachandran, N.; Sarkari, F.; Frappier, L. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog. 2008, 4, e1000170.
9. Sivachandran, N.; Dawson, C.W.; Young, L.S.; Liu, F.F.; Middeldorp, J.; Frappier, L. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J. Virol. 2012, 86, 60-68.
10. Minarovits, J. Microbe-induced epigenetic alterations in host cells: The coming era of patho-epigenetics of microbial infections. A review. Acta Microbiol. Immunol. Hung. 2009, 56, 1-19.
11. Niller, H.H.; Banati, F.; Ay, E.; Minarovits, J. Epigenetic Changes in Virus-Associated Neoplasms. In Patho-Epigenetics of Disease; Minarovits, J., Niller, H.H., Eds.; Springer: New York, NY, USA, 2012; pp. 179-225.
12. Zaret, K.S.; Watts, J.; Xu, J.; Wandzioch, E.; Smale, S.T.; Sekiya, T. Pioneer factors, genetic competence, and inductive signaling: Programming liver and pancreas progenitors from the endoderm. Cold Spring Harb. Symp. Quant. Biol. 2008, 73, 119-126.
13. Kaestner, K.H. The FoxA factors in organogenesis and differentiation. Curr. Opin. Genet. Dev. 2010, 20, 527-532.
14. Cirillo, L.A.; Lin, F.R.; Cuesta, I.; Friedman, D.; Jarnik, M.; Zaret, K.S. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 2002, 9, 279-289.
15. Zaret, K.S.; Carroll, J.S. Pioneer transcription factors: Establishing competence for gene expression. Genes Dev. 2011, 25, 2227-2241.
16. Clark, K.L.; Halay, E.D.; Lai, E.; Burley, S.K. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 1993, 364, 412-420.
17. Zaret, K.S.; Caravaca, J.M.; Tulin, A.; Sekiya, T. Nuclear mobility and mitotic chromosome binding: Similarities between pioneer transcription factor FoxA and linker histone H1. Cold Spring Harb. Symp. Quant. Biol. 2010, 75, 219-226.
18. Hirai, H.; Tani, T.; Kikyo, N. Structure and functions of powerful transactivators: VP16, MyoD and FoxA. Int. J. Dev. Biol. 2010, 54, 1589-1596.
19. Sekiya, T.; Muthurajan, U.M.; Luger, K.; Tulin, A.V.; Zaret, K.S. Nucleosome-binding affinity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA. Genes Dev. 2009, 23, 804-809.
20. Serandour, A.A.; Avner, S.; Percevault, F.; Demay, F.; Bizot, M.; Lucchetti-Miganeh, C.; Barloy-Hubler, F.; Brown, M.; Lupien, M.; Metivier, R. et al. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res. 2011, 21, 555-565.
21. Xu, J.; Pope, S.D.; Jazirehi, A.R.; Attema, J.L.; Papathanasiou, P.; Watts, J.A.; Zaret, K.S.; Weissman, I.L.; Smale, S.T. Pioneer factor interactions and unmethylated CpG dinucleotides mark silent tissue-specific enhancers in embryonic stem cells. Proc. Natl. Acad. Sci. USA 2007, 104, 12377-12382.
22. Xu, J.; Watts, J.A.; Pope, S.D.; Gadue, P.; Kamps, M.; Plath, K.; Zaret, K.S.; Smale, S.T. Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes Dev. 2009, 23, 2824-2838.
23. Smale, S.T. Pioneer factors in embryonic stem cells and differentiation. Curr. Opin. Genet. Dev. 2010, 20, 519-526.
24. Watts, J.A.; Zhang, C.; Klein-Szanto, A.J.; Kormish, J.D.; Fu, J.; Zhang, M.Q.; Zaret, K.S. Study of FoxA pioneer factor at silent genes reveals Rfx-repressed enhancer at Cdx2 and a potential indicator of esophageal adenocarcinoma development. PLoS Genet. 2011, 7, e1002277.
25. Zhang, C.; Wang, L.; Wu, D.; Chen, H.; Chen, Z.; Thomas-Ahner, J.M.; Zynger, D.L.; Eeckhoute, J.; Yu, J.; Luo, J. et al. Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer. Cancer Res. 2011, 71, 6738-6748.
26. Holmqvist, P.H.; Belikov, S.; Zaret, K.S.; Wrange, O. FoxA1 binding to the MMTV LTR modulates chromatin structure and transcription. Exp. Cell Res. 2005, 304, 593-603.
27. Shlomai, A.; Shaul, Y. The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription. Biochem. Biophys. Res. Commun. 2009, 381, 544-548.
28. Bar-Yishay, I.; Shaul, Y.; Shlomai, A. Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression. Liver Int. 2011, 31, 282-290.
29. Yan, J.; Xu, L.; Crawford, G.; Wang, Z.; Burgess, S.M. The forkhead transcription factor FoxI1 remains bound to condensed mitotic chromosomes and stably remodels chromatin structure. Mol. Cell Biol. 2006, 26, 155-168.
30. Blomen, V.A.; Boonstra, J. Stable transmission of reversible modifications: Maintenance of epigenetic information through the cell cycle. Cell Mol. Life Sci. 2011, 68, 27-44.
31. John, S.; Workman, J.L. Bookmarking genes for activation in condensed mitotic chromosomes. Bioessays 1998, 20, 275-279.
32. Xing, H.; Wilkerson, D.C.; Mayhew, C.N.; Lubert, E.J.; Skaggs, H.S.; Goodson, M.L.; Hong, Y.; Park-Sarge, O.K.; Sarge, K.D. Mechanism of hsp70i gene bookmarking. Science 2005, 307, 421-423.
33. Sarge, K.D.; Park-Sarge, O.K. Gene bookmarking: Keeping the pages open. Trends Biochem. Sci. 2005, 30, 605-610.
34. Wilkerson, D.C.; Skaggs, H.S.; Sarge, K.D. HSF2 binds to the Hsp90, Hsp27, and c-Fos promoters constitutively and modulates their expression. Cell Stress Chaperones 2007, 12, 283-290.
35. Xing, H.; Vanderford, N.L.; Sarge, K.D. The TBP-PP2A mitotic complex bookmarks genes by preventing condensin action. Nat. Cell Biol. 2008, 10, 1318-1323.
36. Sarge, K.D.; Park-Sarge, O.K. Mitotic bookmarking of formerly active genes: Keeping epigenetic memories from fading. Cell Cycle 2009, 8, 818-823.
37. Verdeguer, F.; Le Corre, S.; Fischer, E.; Callens, C.; Garbay, S.; Doyen, A.; Igarashi, P.; Terzi, F.; Pontoglio, M. A mitotic transcriptional switch in polycystic kidney disease. Nat. Med. 2010, 16, 106-110.
38. Blobel, G.A.; Kadauke, S.; Wang, E.; Lau, A.W.; Zuber, J.; Chou, M.M.; Vakoc, C.R. A reconfigured pattern of MLL occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit. Mol. Cell 2009, 36, 970-983.
39. Mishra, B.P.; Ansari, K.I.; Mandal, S.S. Dynamic association of MLL1, H3K4 trimethylation with chromatin and Hox gene expression during the cell cycle. FEBS J. 2009, 276, 1629-1640.
40. Bruce, K.; Myers, F.A.; Mantouvalou, E.; Lefevre, P.; Greaves, I.; Bonifer, C.; Tremethick, D.J.; Thorne, A.W.; Crane-Robinson, C. The replacement histone H2A.Z in a hyperacetylated form is a feature of active genes in the chicken. Nucleic Acids Res. 2005, 33, 5633-5639.
41. Kelly, T.K.; Miranda, T.B.; Liang, G.; Berman, B.P.; Lin, J.C.; Tanay, A.; Jones, P.A. H2A.Z maintenance during mitosis reveals nucleosome shifting on mitotically silenced genes. Mol. Cell 2010, 39, 901-911.
42. Kelly, T.K.; Jones, P.A. Role of nucleosomes in mitotic bookmarking. Cell Cycle 2011, 10, 370-371.
43. Young, D.W.; Hassan, M.Q.; Pratap, J.; Galindo, M.; Zaidi, S.K.; Lee, S.H.; Yang, X.; Xie, R.; Javed, A.; Underwood, J.M. et al. Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2. Nature 2007, 445, 442-446.
44. Young, D.W.; Hassan, M.Q.; Yang, X.Q.; Galindo, M.; Javed, A.; Zaidi, S.K.; Furcinitti, P.; Lapointe, D.; Montecino, M.; Lian, J.B. et al. Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2. Proc. Natl. Acad. Sci. USA 2007, 104, 3189-3194.
45. Tandon, M.; Gokul, K.; Ali, S.A.; Chen, Z.; Lian, J.; Stein, G.S.; Pratap, J. Runx2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells. Mol. Cancer 2012, 11, 27.
46. Pockwinse, S.M.; Kota, K.P.; Quaresma, A.J.; Imbalzano, A.N.; Lian, J.B.; van Wijnen, A.J.; Stein, J.L.; Stein, G.S.; Nickerson, J.A. Live cell imaging of the cancer-related transcription factor RUNX2 during mitotic progression. J. Cell Physiol. 2011, 226, 1383-1389.
47. Heinz, S.; Benner, C.; Spann, N.; Bertolino, E.; Lin, Y.C.; Laslo, P.; Cheng, J.X.; Murre, C.; Singh, H.; Glass, C.K. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 2010, 38, 576-589.
48. Ghisletti, S.; Barozzi, I.; Mietton, F.; Polletti, S.; De Santa, F.; Venturini, E.; Gregory, L.; Lonie, L.; Chew, A.; Wei, C.L. et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 2010, 32, 317-328.
49. Pio, F.; Kodandapani, R.; Ni, C.Z.; Shepard, W.; Klemsz, M.; McKercher, S.R.; Maki, R.A.; Ely, K.R. New insights on DNA recognition by ets proteins from the crystal structure of the PU.1 ETS domain-DNA complex. J. Biol. Chem. 1996, 271, 23329-23337.
50. Zhang, P.; Zhang, X.; Iwama, A.; Yu, C.; Smith, K.A.; Mueller, B.U.; Narravula, S.; Torbett, B.E.; Orkin, S.H.; Tenen, D.G. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 2000, 96, 2641-2648.
51. Stopka, T.; Amanatullah, D.F.; Papetti, M.; Skoultchi, A.I. PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure. EMBO J. 2005, 24, 3712-3723.
52. Passner, J.M.; Ryoo, H.D.; Shen, L.; Mann, R.S.; Aggarwal, A.K. Structure of a DNA-bound Ultrabithorax-Extradenticle homeodomain complex. Nature 1999, 397, 714-719.
53. Jabet, C.; Gitti, R.; Summers, M.F.; Wolberger, C. NMR studies of the pbx1 TALE homeodomain protein free in solution and bound to DNA: Proposal for a mechanism of HoxB1-Pbx1-DNA complex assembly. J. Mol. Biol. 1999, 291, 521-530.
54. Moens, C.B.; Selleri, L. Hox cofactors in vertebrate development. Dev. Biol. 2006, 291, 193-206.
55. Magnani, L.; Ballantyne, E.B.; Zhang, X.; Lupien, M. PBX1 genomic pioneer function drives ERalpha signaling underlying progression in breast cancer. PLoS Genet. 2011, 7, e1002368.
56. Lupien, M.; Eeckhoute, J.; Meyer, C.A.; Wang, Q.; Zhang, Y.; Li, W.; Carroll, J.S.; Liu, X.S.; Brown, M. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 2008, 132, 958-970.
57. Burke, L.J.; Zhang, R.; Bartkuhn, M.; Tiwari, V.K.; Tavoosidana, G.; Kurukuti, S.; Weth, C.; Leers, J.; Galjart, N.; Ohlsson, R.; Renkawitz, R. CTCF binding and higher order chromatin structure of the H19 locus are maintained in mitotic chromatin. EMBO J. 2005, 24, 3291-3300.
58. Kennedy, G.; Sugden, B. EBNA-1, a bifunctional transcriptional activator. Mol. Cell Biol. 2003, 23, 6901-6908.
59. Sears, J.; Kolman, J.; Wahl, G.M.; Aiyar, A. Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1. J. Virol. 2003, 77, 11767-11780.
60. Sears, J.; Ujihara, M.; Wong, S.; Ott, C.; Middeldorp, J.; Aiyar, A. The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J. Virol. 2004, 78, 11487-11505.
61. Nayyar, V.K.; Shire, K.; Frappier, L. Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2). J. Cell Sci. 2009, 122, 4341-4350.
62. Bochkarev, A.; Barwell, J.A.; Pfuetzner, R.A.; Bochkareva, E.; Frappier, L.; Edwards, A.M. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA. Cell 1996, 84, 791-800.
63. Cruickshank, J.; Shire, K.; Davidson, A.R.; Edwards, A.M.; Frappier, L. Two domains of the Epstein-Barr virus origin DNA-binding protein, EBNA1, orchestrate sequence-specific DNA binding. J. Biol. Chem. 2000, 275, 22273-22277.
64. Marechal, V.; Dehee, A.; Chikhi-Brachet, R.; Piolot, T.; Coppey-Moisan, M.; Nicolas, J.C. Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J. Virol. 1999, 73, 4385-4392.
65. Wu, H.; Ceccarelli, D.F.; Frappier, L. The DNA segregation mechanism of Epstein-Barr virus nuclear antigen 1. EMBO Rep. 2000, 1, 140-144.
66. Wu, H.; Kapoor, P.; Frappier, L. Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J. Virol. 2002, 76, 2480-2490.
67. Shire, K.; Ceccarelli, D.F.; Avolio-Hunter, T.M.; Frappier, L. EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J. Virol. 1999, 73, 2587-2595.
68. Kapoor, P.; Lavoie, B.D.; Frappier, L. EBP2 plays a key role in Epstein-Barr virus mitotic segregation and is regulated by aurora family kinases. Mol. Cell Biol. 2005, 25, 4934-4945.
69. Hung, S.C.; Kang, M.S.; Kieff, E. Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. Proc. Natl. Acad. Sci. USA 2001, 98, 1865-1870.
70. Sugden, B.; Warren, N. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J. Virol. 1989, 63, 2644-2649.
71. Gahn, T.A.; Sugden, B. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 1995, 69, 2633-2636.
72. Ceccarelli, D.F.; Frappier, L. Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus. J. Virol. 2000, 74, 4939-4948.
73. Mackey, D.; Middleton, T.; Sugden, B. Multiple regions within EBNA1 can link DNAs. J. Virol. 1995, 69, 6199-6208.
74. Mackey, D.; Sugden, B. Studies on the mechanism of DNA linking by Epstein-Barr virus nuclear antigen 1. J. Biol. Chem. 1997, 272, 29873-29879.
75. Frappier, L., O'Donnell, M. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 1991, 88, 10875-10879.
76. Goldsmith, K.; Bendell, L.; Frappier, L. Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication. J. Virol. 1993, 67, 3418-3426.
77. Mackey, D.; Sugden, B. The linking regions of EBNA1 are essential for its support of replication and transcription. Mol. Cell Biol. 1999, 19, 3349-3359.
78. Lu, F.; Wikramasinghe, P.; Norseen, J.; Tsai, K.; Wang, P.; Showe, L.; Davuluri, R.V.; Lieberman, P.M. Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1). Virol. J. 2010, 7, 262.
79. Canaan, A.; Haviv, I.; Urban, A.E.; Schulz, V.P.; Hartman, S.; Zhang, Z.; Palejev, D.; Deisseroth, A.B.; Lacy, J.; Snyder, M. et al. EBNA1 regulates cellular gene expression by binding cellular promoters. Proc. Natl. Acad. Sci. USA 2009, 106, 22421-22426.
80. Dresang, L.R.; Vereide, D.T.; Sugden, B. Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: Defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes. J. Virol. 2009, 83, 2930-2940.
81. D'herouel, A.F., Birgersdotter, A., Werner, M. FR-like EBNA1 binding repeats in the human genome. Virology 2010, 405, 524-529.
82. Altmann, M.; Pich, D.; Ruiss, R.; Wang, J.; Sugden, B.; Hammerschmidt, W. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc. Natl. Acad. Sci. USA 2006, 103, 14188-14193.
83. Aras, S.; Singh, G.; Johnston, K.; Foster, T.; Aiyar, A. Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1. PLoS Pathog. 2009, 5, e1000469.
84. Avolio-Hunter, T.M.; Lewis, P.N.; Frappier, L. Epstein-Barr nuclear antigen 1 binds and destabilizes nucleosomes at the viral origin of latent DNA replication. Nucleic Acids Res. 2001, 29, 3520-3528.
85. Avolio-Hunter, T.M.; Frappier, L. EBNA1 efficiently assembles on chromatin containing the Epstein-Barr virus latent origin of replication. Virology 2003, 315, 398-408.
86. Zhou, J.; Chau, C.M.; Deng, Z.; Shiekhattar, R.; Spindler, M.P.; Schepers, A.; Lieberman, P.M. Cell cycle regulation of chromatin at an origin of DNA replication. EMBO J. 2005, 24, 1406-1417.
87. Chaudhuri, B.; Xu, H.; Todorov, I.; Dutta, A.; Yates, J.L. Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 2001, 98, 10085-10089.
88. Sarkari, F.; Sanchez-Alcaraz, T.; Wang, S.; Holowaty, M.N.; Sheng, Y.; Frappier, L. EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog. 2009, 5, e1000624.
89. Hsieh, C.L. Evidence that protein binding specifies sites of DNA demethylation. Mol. Cell Biol. 1999, 19, 46-56.
90. Lin, I.G.; Tomzynski, T.J.; Ou, Q.; Hsieh, C.L. Modulation of DNA binding protein affinity directly affects target site demethylation. Mol. Cell Biol. 2000, 20, 2343-2349.
91. Ohno, S.; Luka, J.; Lindahl, T.; Klein, G. Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes. Proc. Natl. Acad. Sci. USA 1977, 74, 1605-1609.
92. Grogan, E.A.; Summers, W.P.; Dowling, S.; Shedd, D.; Gradoville, L.; Miller, G. Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding. Proc. Natl. Acad. Sci. USA 1983, 80, 7650-7653.
93. Kanda, T.; Kamiya, M.; Maruo, S.; Iwakiri, D.; Takada, K. Symmetrical localization of extrachromosomally replicating viral genomes on sister chromatids. J. Cell Sci. 2007, 120, 1529-1539.
94. Wilson, J.B.; Bell, J.L.; Levine, A.J. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 1996, 15, 3117-3126.
95. Kang, M.S.; Lu, H.; Yasui, T.; Sharpe, A.; Warren, H.; Cahir-McFarland, E.; Bronson, R.; Hung, S.C.; Kieff, E. Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice. Proc. Natl. Acad. Sci. USA 2005, 102, 820-825.
96. Kang, M.S.; Soni, V.; Bronson, R.; Kieff, E. Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice. J. Virol. 2008, 82, 4180-4183.